← Back
$QNCX All transactions

Quince Therapeutics, Inc.

M

$ Value

$1K

Shares

2,271

Price

$1

Filed

Dec 8

Insider

Name

Hannah Brendan

Title

CBO, COO & CCO

CIK

0001929422

Roles

Officer

Transaction Details

Transaction Date

2025-12-05

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

336,547

Footnotes

Represents grant of 103,500 employee stock options on May 19, 2022, which vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years. | Represents grant of 225,000 employee stock options on February 2, 2023, which vest in equal monthly installments at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, with full vesting on the fourth annual anniversary of the vesting commencement date.

Filing Info

Accession No.

0000912282-25-001370

Form Type

4

Issuer CIK

0001662774

Hannah Brendan's History

Date Ticker Type Value
2026-01-23 QNCX A $0
2025-12-05 QNCX M $1K
2025-12-05 QNCX M $24K
2025-12-05 QNCX M $0
2025-12-05 QNCX M $0
2025-06-18 QNCX A $45K
2025-06-18 QNCX A $5K

Other Insiders at QNCX (90d)

No other insider activity at this issuer in the last 90 days.